Causes of Interstitial Lung Disease
Interstitial lung diseases can be classified into three major etiologic categories: those associated with underlying systemic disorders (particularly autoimmune diseases), those caused by antigenic or toxic exposures (including drugs, occupational, and environmental factors), and idiopathic disorders without identifiable cause. 1
Primary Etiologic Categories
1. Connective Tissue Disease-Associated ILD (CTD-ILD)
CTD-ILD accounts for approximately 20% of all ILDs and represents a substantial subset of cases. 1
Specific autoimmune conditions causing ILD include:
- Systemic sclerosis (SSc-ILD) - accounts for approximately 31% of CTD-ILDs 1
- Rheumatoid arthritis (RA-ILD) - accounts for approximately 39% of CTD-ILDs 1
- Idiopathic inflammatory myopathies (IIM-ILD) - including dermatomyositis, polymyositis, and antisynthetase syndrome 1
- Sjögren's syndrome - causes autoimmune-mediated lymphocytic infiltration of lung parenchyma 2
- Systemic lupus erythematosus 1
- Mixed connective tissue disease 1
2. Environmental and Occupational Exposures
A detailed exposure history is mandatory, as 47% of patients presenting with apparently idiopathic ILD may actually have hypersensitivity pneumonitis when thoroughly evaluated. 1
Critical exposures to investigate include: 1
- Organic antigens: Mold, birds, down feathers, animals, vegetable dust, livestock exposure
- Inorganic dusts: Metal dusts (brass, lead, steel), silica, wood dust (pine)
- Occupational factors: Hair dressing, farming, metalworking
- Hobbies: Bird keeping, woodworking, hot tub use
Occupational exposures to metal, silica, and environmental tobacco smoke increase IPF risk with a pooled odds ratio of 1.7 (95% CI 1.42-2.03), and workplace exposure accounts for 17% (95% CI 7-28%) of hypersensitivity pneumonitis cases. 3
3. Drug-Induced ILD
Medication-induced ILD must be systematically excluded, particularly in patients with CTD already receiving immunosuppressive therapy. 1, 2
High-risk medications include: 2
- TNF-alpha inhibitors - approximately 1% risk
- Methotrexate
- Leflunomide
- Cyclophosphamide
- Rituximab
- Sulfasalazine
- Sulfonamides
This is particularly important because drug-induced ILD can mimic disease progression in patients being treated for CTD-ILD. 2
4. Idiopathic Interstitial Pneumonias
Idiopathic pulmonary fibrosis (IPF) accounts for approximately one-third of all ILD cases and represents over 45% of pulmonary fibrotic disease diagnoses. 1, 4
Other idiopathic forms include nonspecific interstitial pneumonia (NSIP), cryptogenic organizing pneumonia, and lymphoid interstitial pneumonia when no underlying cause is identified. 1
Critical Diagnostic Approach
Before diagnosing idiopathic ILD, you must systematically exclude:
- Medication history - comprehensive review of all current and recent drugs 1
- Environmental exposures - using structured questionnaires for home, work, and frequently visited locations 1
- Connective tissue disease - through serologic testing and clinical evaluation 1
- Occupational exposures - including mineral particles and specific workplace hazards 2
The American Thoracic Society emphasizes that this exclusion process is mandatory because identification and removal of causative factors may result in improved clinical outcomes. 1
Common Pitfalls to Avoid
The most critical error is failing to obtain a sufficiently detailed exposure history. Nearly half of patients initially thought to have idiopathic disease actually have hypersensitivity pneumonitis when properly evaluated. 1
Do not rely solely on patient recall - use standardized questionnaires tailored to cultural habits and geographical differences, as patients often fail to recognize relevant exposures without specific prompting. 1
Consider drug-induced ILD in any patient with CTD-ILD who progresses despite appropriate therapy - the medications used to treat the underlying CTD can themselves cause ILD. 2
Remember that up to 10% of patients with clinically significant ILD may have normal chest radiographs, so HRCT is essential when clinical suspicion exists. 1